PubRank

Elizabeth Sinclair

Author PubWeight™ 116.00‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy. J Infect Dis 2003 8.00
2 Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection. J Infect Dis 2009 6.17
3 Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy. J Infect Dis 2008 6.03
4 Standardization of cytokine flow cytometry assays. BMC Immunol 2005 4.55
5 T cell activation and senescence predict subclinical carotid artery disease in HIV-infected women. J Infect Dis 2011 3.38
6 HLA class I-restricted T-cell responses may contribute to the control of human immunodeficiency virus infection, but such responses are not always necessary for long-term virus control. J Virol 2008 3.36
7 A randomized, controlled trial of raltegravir intensification in antiretroviral-treated, HIV-infected patients with a suboptimal CD4+ T cell response. J Infect Dis 2011 3.10
8 Phenotypic, functional, and kinetic parameters associated with apparent T-cell control of human immunodeficiency virus replication in individuals with and without antiretroviral treatment. J Virol 2005 3.07
9 Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responses. AIDS 2006 2.98
10 Differences in HIV burden and immune activation within the gut of HIV-positive patients receiving suppressive antiretroviral therapy. J Infect Dis 2010 2.98
11 Effect of raltegravir-containing intensification on HIV burden and T-cell activation in multiple gut sites of HIV-positive adults on suppressive antiretroviral therapy. AIDS 2010 2.94
12 Analyses and comparisons of telomerase activity and telomere length in human T and B cells: insights for epidemiology of telomere maintenance. J Immunol Methods 2009 2.78
13 Valganciclovir reduces T cell activation in HIV-infected individuals with incomplete CD4+ T cell recovery on antiretroviral therapy. J Infect Dis 2011 2.56
14 Neutralizing antibody responses against autologous and heterologous viruses in acute versus chronic human immunodeficiency virus (HIV) infection: evidence for a constraint on the ability of HIV to completely evade neutralizing antibody responses. J Virol 2006 2.50
15 Challenges in detecting HIV persistence during potentially curative interventions: a study of the Berlin patient. PLoS Pathog 2013 2.44
16 Growth hormone enhances thymic function in HIV-1-infected adults. J Clin Invest 2008 2.35
17 Comparison of the ELISPOT and cytokine flow cytometry assays for the enumeration of antigen-specific T cells. J Immunol Methods 2003 2.28
18 Antiretroviral therapy initiated within 6 months of HIV infection is associated with lower T-cell activation and smaller HIV reservoir size. J Infect Dis 2013 2.23
19 Cytomegalovirus immunoglobulin G antibody is associated with subclinical carotid artery disease among HIV-infected women. J Infect Dis 2012 2.16
20 Human CD4+ regulatory T cells express lower levels of the IL-7 receptor alpha chain (CD127), allowing consistent identification and sorting of live cells. J Immunol Methods 2006 2.14
21 Prospective antiretroviral treatment of asymptomatic, HIV-1 infected controllers. PLoS Pathog 2013 2.06
22 Cell-based measures of viral persistence are associated with immune activation and programmed cell death protein 1 (PD-1)-expressing CD4+ T cells. J Infect Dis 2012 1.86
23 Cytomegalovirus-specific T cells persist at very high levels during long-term antiretroviral treatment of HIV disease. PLoS One 2010 1.83
24 The HIV-1 reservoir in eight patients on long-term suppressive antiretroviral therapy is stable with few genetic changes over time. Proc Natl Acad Sci U S A 2013 1.80
25 Immunologic and virologic evolution during periods of intermittent and persistent low-level viremia. AIDS 2004 1.75
26 Performance of plate-based cytokine flow cytometry with automated data analysis. BMC Immunol 2003 1.66
27 T cell activation predicts carotid artery stiffness among HIV-infected women. Atherosclerosis 2011 1.64
28 Multisite comparison of high-sensitivity multiplex cytokine assays. Clin Vaccine Immunol 2011 1.62
29 Strong cell-mediated immune responses are associated with the maintenance of low-level viremia in antiretroviral-treated individuals with drug-resistant human immunodeficiency virus type 1. J Infect Dis 2004 1.58
30 A low T regulatory cell response may contribute to both viral control and generalized immune activation in HIV controllers. PLoS One 2011 1.43
31 The distribution of HIV DNA and RNA in cell subsets differs in gut and blood of HIV-positive patients on ART: implications for viral persistence. J Infect Dis 2013 1.39
32 Hematopoietic precursor cells isolated from patients on long-term suppressive HIV therapy did not contain HIV-1 DNA. J Infect Dis 2012 1.30
33 Expression profile of host restriction factors in HIV-1 elite controllers. Retrovirology 2013 1.24
34 Loss of T cell responses following long-term cryopreservation. J Immunol Methods 2007 1.23
35 The independent effect of drug resistance on T cell activation in HIV infection. AIDS 2006 1.22
36 Raltegravir treatment intensification does not alter cerebrospinal fluid HIV-1 infection or immunoactivation in subjects on suppressive therapy. J Infect Dis 2011 1.15
37 A randomized controlled trial assessing the effects of raltegravir intensification on endothelial function in treated HIV infection. J Acquir Immune Defic Syndr 2012 1.09
38 HIV-specific CD4+ T cells may contribute to viral persistence in HIV controllers. Clin Infect Dis 2011 1.03
39 High CD8+ T cell activation marks a less differentiated HIV-1 specific CD8+ T cell response that is not altered by suppression of viral replication. PLoS One 2009 1.02
40 Flow cytometric detection of Ewing sarcoma cells in peripheral blood and bone marrow. Pediatr Blood Cancer 2010 1.02
41 A comparison of methods for measuring rectal HIV levels suggests that HIV DNA resides in cells other than CD4+ T cells, including myeloid cells. AIDS 2014 0.98
42 Cellular Composition of Cerebrospinal Fluid in HIV-1 Infected and Uninfected Subjects. PLoS One 2013 0.96
43 A CMV DNA vaccine primes for memory immune responses to live-attenuated CMV (Towne strain). Vaccine 2009 0.96
44 Immunosenescence is associated with presence of Kaposi's sarcoma in antiretroviral treated HIV infection. AIDS 2013 0.95
45 Programmed death-1 expression on CD4⁺ and CD8⁺ T cells in treated and untreated HIV disease. AIDS 2014 0.95
46 Geriatric trauma: demographics, injuries, and mortality. J Orthop Trauma 2012 0.92
47 Safety and immunogenicity of Towne cytomegalovirus vaccine with or without adjuvant recombinant interleukin-12. Vaccine 2006 0.92
48 Comparison of HIV DNA and RNA in gut-associated lymphoid tissue of HIV-infected controllers and noncontrollers. AIDS 2013 0.92
49 Human herpesvirus replication and abnormal CD8+ T cell activation and low CD4+ T cell counts in antiretroviral-suppressed HIV-infected patients. PLoS One 2009 0.90
50 IL-2 immunotherapy to recently HIV-1 infected adults maintains the numbers of IL-17 expressing CD4+ T (T(H)17) cells in the periphery. J Clin Immunol 2010 0.89
51 Antigen-specific T cell responses induced by Towne cytomegalovirus (CMV) vaccine in CMV-seronegative vaccine recipients. J Clin Virol 2006 0.87
52 Immune activation, CD4+ T cell counts, and viremia exhibit oscillatory patterns over time in patients with highly resistant HIV infection. PLoS One 2011 0.86
53 Minocycline fails to modulate cerebrospinal fluid HIV infection or immune activation in chronic untreated HIV-1 infection: results of a pilot study. AIDS Res Ther 2011 0.86
54 Development of cytomegalovirus (CMV) immune recovery uveitis is associated with Th17 cell depletion and poor systemic CMV-specific T cell responses. Clin Infect Dis 2010 0.86
55 Poor predictive value of cytomegalovirus (CMV)-specific T cell assays for the development of CMV retinitis in patients with AIDS. Clin Infect Dis 2008 0.84
56 HIV-1 infection abrogates CD8+ T cell mitogen-activated protein kinase signaling responses. J Virol 2011 0.82
57 Peripheral neuropathy in primary HIV infection associates with systemic and central nervous system immune activation. J Acquir Immune Defic Syndr 2014 0.80
58 Cortisol patterns are associated with T cell activation in HIV. PLoS One 2013 0.80
59 HIV-producing T cells in cerebrospinal fluid. J Acquir Immune Defic Syndr 2004 0.80
60 Is implicit learning spared in amnesia? Rule abstraction and item familiarity in artificial grammar learning. Neuropsychologia 2002 0.79
61 Endothelial cell high-enrichment from endovascular biopsy sample by laser capture microdissection and fluorescence activated cell sorting. J Biotechnol 2014 0.79
62 Clinical findings and prognostic factors for dogs undergoing cholecystectomy for gall bladder mucocele. Vet Surg 2013 0.79
63 Social cognition in Tourette's syndrome: intact theory of mind and impaired inhibitory functioning. J Autism Dev Disord 2004 0.77
64 Correction: A novel minimally-invasive method to sample human endothelial cells for molecular profiling. PLoS One 2015 0.75
65 Correction: Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized Trial. PLoS Pathog 2016 0.75
66 A Novel Minimally-Invasive Method to Sample Human Endothelial Cells for Molecular Profiling. PLoS One 2015 0.75
67 Correction: Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized Trial. PLoS Pathog 2017 0.75
68 Immunologic profiles distinguish aviremic HIV-infected adults. AIDS 2016 0.75
69 Mucinous adenocarcinoma of the breast metastatic to the placenta. Pathology 2010 0.75